ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
High-Sensitive Mass Cytometry Metal Tags Based on Noble Metal Nanoparticles Assisting Acute Myeloid Leukemia Immune Checkpoint Profiling.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Mass cytometry is optimal for acute leukemia immune checkpoint profiling. However, current commercial metal-chelating polymer (MCP) metal tags limit its sensitivity due to low metal loading capacity. We report a novel synthetic strategy employing antibody-conjugated gold or platinum nanoparticles (AuNP/PtNP) for high-dimensional single-cell immunophenotyping in both single cell suspension mass cytometry and imaging mass cytometry. Extremely low-dose AuNP (34 NPs/cell) exhibited MCP-comparable sensitivity, while high doses enabled up to 48-fold signal amplification. Furthermore, integration of the detection of low-abundance TIGIT and OX40 by AuNP/PtNP tags and other 22 biomarkers by MCP tags, three significantly distinct T cell subpopulations in healthy donor and acute myeloid leukemia samples were identified, providing new targets and intervention strategies for the diagnosis and treatment of acute myeloid leukemia. The proposed strategies demonstrate that noble metal NP-based tags show promising potential in detection of low-abundance cell surface biomarkers and enhance MC implementation in both biomedical and clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.